IMC Chicago’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.3M Buy
254,700
+192,700
+311% +$18.1M ﹤0.01% 1117
2026
Q1
$7.33M Sell
62,000
-69,600
-53% -$8.61M ﹤0.01% 1502
2025
Q4
$16.6M Sell
131,600
-3,100
-2% -$404K 0.01% 938
2025
Q3
$19.7M Buy
134,700
+71,900
+114% +$10.9M 0.01% 795
2025
Q2
$9.79M Buy
62,800
+28,200
+82% +$4.47M ﹤0.01% 1023
2025
Q1
$5.7M Sell
34,600
-15,700
-31% -$2.61M ﹤0.01% 1168
2024
Q4
$8.2M Buy
50,300
+25,800
+105% +$4.61M ﹤0.01% 1009
2024
Q3
$4.79M Buy
24,500
+4,900
+25% +$903K ﹤0.01% 1153
2024
Q2
$3.4M Buy
+19,600
New +$3.26M ﹤0.01% 1251

Other funds holding ZTS

IMC Chicago's ZTS Position: Q2 2026 in Review

IMC Chicago increased its Zoetis (ZTS) stake by 384% in Q2 2026, buying an estimated $5.06M and bringing the position to 67,756 shares worth $4.87M. The position accounts for ﹤0.01% of the portfolio, ranked #2115.

IMC Chicago first reported a position in ZTS in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.53M in Q2 2025. 1,429 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • IMC Chicago held 67,756 shares of Zoetis worth $4.87M as of Q2 2026.
  • IMC Chicago bought 53,767 Zoetis shares in Q2 2026, an estimated $5.06M.
  • Zoetis made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #2115 holding.
  • IMC Chicago first reported a position in Zoetis in Q1 2025 and has held it in 6 quarters since.
  • IMC Chicago's Zoetis position peaked at $5.53M in Q2 2025.
  • 1,429 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.